AEGERION PHARMACEUTICALS INC
Q2 2019 13F Holders
CUSIP
00767EAB8
Type
Debt
Class
NOTE 2.000% 8/1
Num filings
2
Total reported value, excl. options
$36.7 M
Compare 2019 Q2 to
2020 Q1
2019 Q4
2019 Q3
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
Manager
Report Date
Value ($000)
Principal
Option Type